Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s Why

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $14.61, but opened at $14.00. Terumo shares last traded at $14.57, with a volume of 4,261 shares.

Terumo Price Performance

The firm has a market capitalization of $21.73 billion, a price-to-earnings ratio of 24.47 and a beta of 0.75. The company has a quick ratio of 1.46, a current ratio of 2.51 and a debt-to-equity ratio of 0.07. The company’s fifty day moving average is $15.15 and its two-hundred day moving average is $16.51.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Wednesday, November 12th. The company reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.75 billion. Terumo had a net margin of 12.35% and a return on equity of 9.39%.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.